J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 11,190
+630 (5.97%)
At close: Aug 11, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 65.43 billion as of August 11, 2026. Its market cap has increased by 12.35% in one year.
Market Cap
65.43B
Enterprise Value
57.17B
Revenue
36.82B
Ranking
n/a
PE Ratio
16.19
Stock Price
11,190.00
ChartMarket Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 65.43B, a decrease of -54.85%. That is a compound annual growth rate of -28.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 65.43B | 30.12% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
| Mar 25, 2024 | 144.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IMGT Co.,Ltd. | 68.17B |
| PanGen Biotech | 67.44B |
| AriBioLab | 65.13B |
| KoBioLabs | 64.37B |
| NovMetaPharma | 62.35B |
| Naturalendo Tech | 58.88B |
| ABION | 58.30B |
| Aptamer Sciences | 57.99B |